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Ubiquitin, which is ligated covalently to target proteins for their acquisition of a variety of functions, is encoded by multiple unique genes in human 
cells: two distinct poly-ubiquitin genes with tandemly repeated sequences of 3 or 9 moieties and two mono-ubiquitin genes fused with small and 
large ribosomal proteins. We found that all classes of ubiquitin genes as well as the two genes encoding the ribosomal proteins 517 and L31 were 
expressed at abnormally high levels in various hematopoietic malignant umor cells. In contrast, in vitro terminal differentiation of various immature 
leukemic cell lines, such as HL-60 promyelocytic leukemia cells and K562 erythroleukemia cells into monocytic, granulocytic and erythroid cells, 
induced by various agents was found to cause rapid and marked down-regulation of ubiquitin expression, irrespective of the cell type, direction 
of differentiation or type of signal. These findings suggest hat the expressions of the multiple ubiquitin genes, coordinated with those of the 
ribosomal protein genes, are in a dynamic state during growth and differentiation of leukemia cells. 
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1. INTRODUCTION 
Ubiquitin (Ub) is an evolutionally conserved protein, 
consisting of 76 amino acid residues, and for post- 
translational modification of various proteins it is 
covalently conjugated to these proteins through multi- 
enzymatic reactions [I]. Of the many cellular processes 
in which the Ub system is involved, we are especially 
interested in cell proliferation, because during this proc- 
ess various important proteins related with cell cycle 
progression, such as cyclin, ~53, c-Mos, platelet-derived 
growth factor receptor and T cell antigen receptor, are 
degraded by the Ub pathway. Ub serves as a degrada- 
tion signal for proteolytic attack, and the breakdown of 
ubiquitinated protein is catalyzed by an ATP-dependent 
proteolytic complex containing a proteasome [2-4]. Re- 
cently, we found that the proteasome also plays an es- 
sential role in cell growth [4] and that the expressions 
of multiple proteasome genes are markedly down-regu- 
lated during in vitro induction of terminal differentia- 
tion of various types of immature human leukemic cell 
lines [5]. In the present study, we examined changes in 
the expressions of the multiple Ub genes during differ- 
entiation of leukemic cells. 
2. MATERIALS AND METHODS 
The materials used were as follows: [a-3ZP]dCTP (I 10 TBq/mmol), 
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and Hybond-N’ nylon membranes (Amersham); TPA (12~O-tetradec- 
anoylphorbol-13-acetate), retinoic acid, hemin, sphinganine and anti- 
Ub antibody (Sigma); 1,25-dihydroxyvitamin D3, 1,25(OH),D, 
(DuPhar, Amsterdam) and H7 (Funakoshi, Tokyo). The human cell 
lines HL-60 (promyelocytic ells), K562 (erythroleukemia cells), U937 
(histiocytic cells) and THPl (acute monocytic leukemia cells) were 
maintained as stationary suspension cultures in RPMI-1640 medium 
as described [S]. RNA blot hyb~dization was performed with 10 pg 
of total RNA extracted from cultured cells and 32P-Iabelled probes as 
described previously [5]. For measuring the levels of four mRNAs for 
Ub, three cDNAs were used: one was a poly-UbB cDNA for detection 
of all classes of Ub mRNAs. The other two were cDNAs of about 250 
bp corresponding to the C-terminal extension sequences (UBCP) of 
mono-UbA,, and mono-UbA,, cDNAs (for details, see [6]). cDNAs 
encoding the rat ribosomal proteins S17 [7] and L31 [8], the 3rd exon 
of the human c-myc gene and the cDNA of /I-actin (Oncr Inc.) were 
also used. Immunoelectrophoretic blot analysis was carried out by the 
method of Towbin et al. 191. Samples of cell extracts (50 pg) were 
separated by SDS-PAGE, transferred electrophoretically to a 
Hybond-C membrane (Amersham) and treated with anti-Ub anti- 
bodies (Sigma). [‘*‘I]Protein A was used as the second antibody. 
3. RESULTS 
3.1. Levels of mRNAs transcribed from 4 classes of Ub 
genes during differentiation of leukemia cells 
On Northern blot analysis with Ub-cDNA, three dis- 
tinct mRNAs of 2.6, 1.2 and 0.6 kb were detected in 
total RNAs extracted from human HL-60 leukemia 
cells with poly-UbC, poly-UbB and two mono-UbAs, 
respectively [6], whereas with the UBCP-UbA~* and 
UBCP-UbA,, probes, corresponding to small and large 
ribosomal proteins, respectively [lo], mRNAs with ap- 
proximately similar lengths of 0.6 kb were detected (Fig. 
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Fig. 1. Down-regulation of the expression of mRNAs encoding Ub during monocytic differentiation of promyelocytic leukemic HL-60 cells. (A) 
Time course: HL-60 cells (3 x 10’ cells/ml) were treated with 5 x lo-’ M TPA (left panel) or 5 x low7 M 1,25(OH),D, (right pznel) for the indicated 
times. (B) Effects of C-kinase inhibitors: HL-60 cells were treated for 48 h with TPA or 1,25(OH),D, (1,25-D,) in the presence or absence of 18 
FM H7 or 6pM sphinganine (Sa). Total RNA (1Opg) extracted from these cells was used for Northern blot analysis with three classes of Ub cDNAs, 
c-myc and actin as probes. 
1). Interestingly, the levels of all Ub mRNAs were quite 
low in human peripheral lymphocytes and monocytes 
(data not shown), suggesting that abnormally high ex- 
pression of multiple Ub genes is closely related to rapid 
proliferation of hematopoietic ells. As shown in Fig. 
1A (left panel), treatment of HL-60 cells with TPA 
caused marked down-regulation of the levels of mRNAs 
transcribed from all classes of Ub genes, although the 
decrease of the mRNA encoding the largest poly-UbC 
was relatively small. This down-regulation was rapid, 
indicating half-lives of less than 3 h during stimulation, 
suggesting rapid turnover of the mRNAs. Similar 
down-regulations of the Ub mRNA levels were ob- 
served during monocytic differentiation induced by 
1,25(OH),D,, although the disappearance of the 
mRNAs was slower than during treatment with TPA 
(Fig. 2A, right panel). Thus down-regulation of Ub ex- 
pression seems to be independent of the type of signal. 
Intracellular transduction of the signal of TPA is 
known to be mediated by protein kinase C, so we exam- 
ined whether down-regulation of Ub by 1,25(OH),D, 
was mediated through a similar C-kinase pathway. For 
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this, we tested the effects of C-kinase inhibitors, such as 
H7 [7] and sphinganine [8] on the down-regulation of 
Ub expression during treatment of HL-60 cells with 
these inducing agents. As shown in Fig. 1 B, down-regu- 
lation of Ub genes in HL-60 cells induced by TPA was 
markedly blocked by the presence of H7 or sphinganine, 
but these two inhibitors had no effect on the decrease 
of the mRNA levels of Ub during 1,25(0H),D,-induced 
monocytic differentiation of these cells except for par- 
tial inhibition of poly-UbC gene expression by sphin- 
ganine. These findings suggest that protein kinase C is 
involved in the TPA-mediated pathway of down-regula- 
tion of Ub genes, but not in the 1,25(0H),D,-dependent 
pathway. Thus, the mechanisms of down-regulations of 
Ub genes induced by TPA and 1,25(OH),D, seem to be 
different. These two inhibitors alone had no effect on 
the mRNA levels of Ubs, suggesting that down-regula- 
tion of Ub expression is not dependent on the intracellu- 
lar pathway for signal transduction evoked by TPA and 
1,25(OH),D, and that differentiation of the cells itself 
is important for their down-regulating effects. 
It was of interest to determine whether TPA-induced 
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down-regulation of Ubs was specific for HL-60 cells. To 
examine this, we measured alterations of the Ub mRNA 
levels during TPA-induced monocytic differentiation of 
other types of cells. As shown in Fig. 2A, TPA caused 
marked decreases in the levels of multiple Ub mRNAs 
in U937, THPl and K562 cells, suggesting that down- 
regulation of Ub gene expression induced by TPA is 
independent of the cell type. We also examined whether 
down-regulation of Ubs was specific to monocytic dif- 
ferentiation of cells by studies on HL-60 cells treated 
with DMSO and retinoic acid to induce their differenti- 
ation into granulocytic cells, and K562 cells treated with 
n-butyric acid (BuAc) and hemin to induce their 
erythroid differentiation. Results showed marked 
down-regulation of Ubs during both granulocytic dif- 
ferentiation of HL-60 cells (Fig. 2B), and erythroid dif- 
ferentiation of K562 cells (Fig. 2C), indicating that 
down-regulation of the family of Ub genes is independ- 
ent of the direction of differentiation. 
3.2. Levels of mRNAs encoding S17 and WI ribosomal 
proteins during differentiation of leukemia cells 
As mono-Ub genes are fused with ribosomal protein 
genes, we examined whether the expression of genes 
encoding other ribosomal proteins is coordinated to 
those of mono-Ub genes. For this, we compared the 
mRNA levels of two ribosomal proteins, S 17 and L3 1, 
with those of mono-Ub mRNAs and found that these 
two types of mRNAs decreased similarly on treatment 
with various inducing reagents, irrespective of the cell 
type, direction of differentiation or type of signal (Figs. 
1 and 2). Interestingly, the effect of C-kinase inhibitors, 
such as H7 and sphinganine, on the expression of these 
ribosomal proteins was also similar to those of the two 
mono-Ub genes, suggesting that down-regulation of the 
expression of ribosomal protein genes encoded by the 
mono-Ub genes is coordinated with those of other ribo- 
somal proteins. In contrast, the level of actin mRNA did 
not change significantly during any of the treatments 
examined. 
3.3. In vitro differentiation of human leukemia cell lines 
During these experiments, we examined differentia- 
tion of cells in several ways. We found microscopically 
that marked morphological changes occurred on treat- 
ments with various inducers, as indicated by aggrega- 
tion of the cells and their tight attachment to the culture 
dishes (data not shown). Rapid down-regulation of the 
mRNA levels of the proto-oncogene c-myc has been 
used as a marker of differentiation in a blood-cell cul- 
ture system [ 131. We also observed a decrease in c-myc 
mRNA levels during induction of differentiation of all 
leukemic cells examined (Figs. 1 and 2). However, un- 
like the effect of C-kinase inhibitors such as H7 or 
sphinganine on the down-regulation of expression of 
ubiquitin and ribosomal genes, these inhibitors did not 
prevent down-regulation of the mRNA level of c-myc 
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Fig. 2. Effects of cell type and direction of differentiation on down- 
regulation of expressions of multiple Ub genes. (A) U937, THPl and 
K562 cells (3 x 10’ cells/ml) were treated for 72 h with TPA. (B) HL-60 
cells were treated for 72 h with 1.25% DMSO or 1 .O x 10m6 M retinoic 
acid (RA). (C) KS62 cells were treated for 120 h with 1.4 x 10m2 M
n-butyric acid (BuAc) or 5 x lO-‘M hemin. Northern blot analysis was 
performed as for Fig. 1. The direction of differentiation of the cells 
examined is shown at the bottom. 
by TPA (Fig. 1 B), suggesting that TPA down-regulates 
the c-myc gene by another pathway not involving C- 
kinase. Interestingly, these C-kinase inhibitors caused 
partial inhibition of the down-regulation of c-myc in- 
duced by 1,25(OH),D,, which is consistent with a report 
by others [14]. Thus, the mechanisms of down-regula- 
tion of c-myc gene expression induced by TPA and 
1,25(OH),D, seem to be different. 
Monocytic and granulocytic differentiations were de- 
tected by measuring the change in activity for reduction 
of nitroblue tetrazolium (NBT), and erythroid differen- 
tiation was monitored as the production of hemoglobin 
staining with benzidine. After 3 days treatment, almost 
all the HL-60 cells were NBT-positive in cultures with 
TPA, and 55-95% were NBT-positive in cultures with 
1,25(OH),D,, retinoic acid or DMSO (data not shown). 
Cultures of unstimulated control HL-60 cells contained 
less than 5% NBT-positive cells. Hemin and BuAc 
237 
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caused similar inductions of differentiation of K562 
cells, as judged by measurement of benzidine-positive 
cells (data not shown). 
3.4. Patterns of ubiquitinatedproteins during differentia- 
tion of leukemia cells 
As Ub is normally ligated to various cellular proteins, 
we compared the patterns of ubiquitinated proteins dur- 
ing differentiation of HL-60 and K562 cells. Ubiquiti- 
nated proteins were analyzed by immunoblotting with 
anti-Ub polyclonal antibodies. As shown in Fig. 3, the 
patterns of cellular proteins ubiquitinated in HL-60 cells 
and in K562 cells were somewhat different, suggesting 
cell type-specific ubiquitination. Moreover, differentia- 
tion of HL-60 cells into monocytic cells caused disap- 
pearance of certain components, increases in intensity 
of many bands and the appearances of some faint new 
bands. Similar changes were also observed during gran- 
ulocytic differentiation of these cells. Differentiation- 
dependent changes in ubiquitination of cellular proteins 
were also observed during differentiation of K562 cells 
into monocytic and erythroid cells. Interestingly, simi- 
lar monocytic differentiations of these two cell types 
resulted in different ubiquitination patterns, suggesting 
that the terminal-differentiated phenotypes of these cells 
are different. The biological significance of differentia- 
tion-specific ubiquitinations of various cellular proteins 
is unknown. 
4. DISCUSSION 
The differentiation-dependent down-regulation of 
multiple Ub genes in immature human leukemic cells 
observed in this work resembles that of the proteasome 
that we reported before [5]. The expression of these Ub 
and proteasome genes may well be coordinated, because 
these two types of gene products are involved in the 
same degradation system, consisting of selective recog- 
nition of target proteins by Ub and their subsequent 
destruction by the proteasome [2-4]. Moreover, differ- 
entiation of leukemic cells not only caused down-regula- 
tion of expression of the poly-Ub genes that increase the 
cellular Ub pool, but also of the mono-Ub genes. The 
latter effect may be related to ribosome biogenesis, be- 
cause mono-Ub genes produce ribosomal proteins as 
well as the Ub moiety [l, lo], and because the mRNA 
levels of two ribosomal proteins, S17 and L31, changed 
in a similar fashion to those of the mono-Ub genes 
(Figs. 1 and 2). Previous studies have shown that the 
ribosome content is high in rapidly growing cells with 
high protein-synthesizing activity, and that differentia- 
tion of leukemic cells is always associated with with- 
drawal from the cell proliferation. Errors of transcrip- 
tion and translation could be high during protein syn- 
thesis in rapidly proliferating cells with an increase in 
the possibility of the generation of abnormal proteins. 
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Fig. 3. Detection of ubiquitinated proteins in crude extracts from 
leukemic ells by immuno-blot analysis. Panels A and B show results 
with extracts of HL-60 and K562 cells, respectively. The cells were 
treated with various inducers, as for Figs. 1 and 2. Samples of 50 pg 
of cell proteins were subjected to SDS-PAGE. Immunoblot analysis 
was carried out as described in section 2. The positions of M, marker 
proteins are shown at the right. 
The observed growth-dependent decrease in the 
mRNAs producing Ub and proteasomes [5] in cells may 
result in the loss of an ATP/Ub-dependent proteolytic 
system responsible for maintaining cellular homeostasis 
by preventing accumulation of abnormal proteins gen- 
erated by biosynthetic errors. 
In the present study, we found that ubiquitination of 
proteins showed cell-specific patterns (Fig. 3), which 
were not affected by Ub gene expression. Previously, we 
reported specific ubiquitinated proteins in cancerous 
parts of human renal cell carcinomas [6], suggesting that 
specific ubiquitination occurs commonly during carcin- 
ogenesis or differentiation in various cells. At present, 
it is unknown whether the heterogeneity in size of ubiq- 
uitinated proteins is due to mono-ubiquitination of dif- 
ferent cellular proteins or multi-ubiquitination of the 
same proteins. However, the latter possibility is un- 
likely, because multi-ubiquitinated proteins are believed 
to be degraded rapidly by the proteasome system in 
cells, and normal intermediates of proteolysis cannot be 
detected in the cells. Thus, the ubiquitination of cellular 
proteins shown in Fig. 3 may differ from the acquisition 
of a degradation signal. Therefore, it is of importance 
to identify and characterize the proteins ubiquitinated 
in a proliferation- and differentiation-specific manner. 
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